Comtess (Entacapone) 200 MG is a medication used as an adjunct treatment for patients with Parkinson’s disease who are experiencing motor fluctuations while on a stable dose of levodopa/carbidopa. It helps enhance the effectiveness of these medications, improving overall motor control.

Key Features:

COMT Inhibitor: Comtess works by inhibiting catechol-O-methyltransferase (COMT), an enzyme that breaks down levodopa, thereby prolonging its effects and improving symptoms of Parkinson’s disease.
Improved Motor Function: By increasing the duration of levodopa action, Comtess can help reduce “off” times and improve overall mobility and quality of life for patients.
Convenient Packaging: Supplied in a pack of 30 tablets, providing a month’s supply for easy management of treatment regimens.
Well-Tolerated: Most patients tolerate Comtess well, with a manageable side effect profile.

Very secured payment methods

Shipping will be calculated on checkout

Please note that price may increase due to exchange rate, ensure updated price before making payment